Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Tag: Betadex Sulfobutyl Ether Sodium

November 12, 2019 Drug delivery / Pharma applications

Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

Ligand Pharmaceuticals Incorporated presented positive results from a Phase 1 clinical trial of its Captisol-enabled (CE) Iohexol program at ASN

Continue reading

June 26, 2019 CD as API / CD derivatives / Pharma applications

Clinical trial on Noninfectious Anterior Uveitis – SBECD offering disease resolution

Aldeyra Therapeutics Announced Results from the SOLACE Trial in Noninfectious Anterior Uveitis. The main points are: Statistical Significance Not Achieved

Continue reading

November 17, 2018 Drug delivery / Pharma applications

Sage Therapeutics Announces FDA Advisory Committee Votes 17-1 in Support of Benefit-Risk Profile of ZULRESSO™ (brexanolone) Injection for Treatment of Postpartum Depression

If approved, ZULRESSO would be the first medicine specifically indicated for the treatment of postpartum depression (PPD) Sage Therapeutics (NASDAQ:

Continue reading

November 16, 2018 Drug delivery / Pharma applications

Melinta Therapeutics Announces Positive Top-Line Results in Phase III Trial of Baxdela® (delafloxacin) for Treatment of CABP

Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, announced positive

Continue reading

October 16, 2018 Pharma applications

Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of

Continue reading

October 16, 2018 Events / Pharma applications

Melinta Therapeutics to Give New Presentations on Antibiotics Portfolio and Pipeline at IDWeek™ 2018

Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, delivered eight

Continue reading

October 16, 2018 Pharma applications

FDA Approves KYPROLIS® (carfilzomib) In Combination With Dexamethasone For Patients With Relapsed Or Refractory Multiple Myeloma

Amgen (NASDAQ:AMGN) recently announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA)

Continue reading

September 18, 2018 Drug delivery / Pharma applications

Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)

Amgen announced on the 27th August, 2018 the submission of a supplemental New Drug Application (sNDA) to the U.S. Food

Continue reading

September 6, 2018 CD derivatives / Pharma applications

Improved method for the preparation of SBECD – In which aspect?

Recently, a new patent application became accessible to the public, WO2018146698 (A1), filed by Biophore India, a DMF holder for the

Continue reading

September 6, 2018 Drug delivery / Events / Pharma applications

Cyclodextrins at CPHI Worldwide

The biggest pharma exhibition in the world, CPHI Worldwide will be organized 9-11th October in Madrid. By joining (which is

Continue reading

Posts navigation

1 2 Next Posts»

Recent Posts

  • Effect of buffers on the stability of SBECD complexes
  • Solution Density Models as Functions of Sodium Chloride, HPBCD, and temperature
  • New approach in ocular drug delivery: cyclodextrin-containing mucoadhesive eye drop formulations
  • Cochlear spiral ganglion neuron degeneration following cyclodextrin-induced hearing loss
  • Low-cost hydrogel adsorbent enhanced by trihydroxy melamine and β-cyclodextrin for the removal of Pb(II) and Ni(II) in water

Tags

antiviral Betadex Sulfobutyl Ether Sodium Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems Drugs FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease Polymer remdesivir SBECD Special issue Synthesis Trappsol

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (8)
  • Analysis (12)
  • CD as API (99)
  • CD derivatives (123)
  • Cosmetics and toilettry (10)
  • Drug delivery (191)
  • E-ducation (41)
  • Environmental (41)
  • Events (97)
  • Food (57)
  • Gene delivery (6)
  • In Hungarian (4)
  • Non-pharma applications (97)
  • Other industrial use (34)
  • Pharma applications (350)
  • Supramolecular systems (7)
  • Uncategorized (23)

Top Posts

  • Effect of buffers on the stability of SBECD complexes
  • Solution Density Models as Functions of Sodium Chloride, HPBCD, and temperature
  • The use of β-CDs to improve honey bee health
  • New approach in ocular drug delivery: cyclodextrin-containing mucoadhesive eye drop formulations
  • Cyclodextrins as possible antidotes to box jellyfish venom
  • World Biotechnology Industry Conference-2020 (WBC-2020)
  • Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
  • International Cyclodextrin Symposium 2020
  • Effect of β-CD on gut microbiota
  • NIH funds study to evaluate remdesivir for COVID-19 in pregnancy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 288 other subscribers